title: Protective and pathological activity in serum of mice developing resistance to Plasmodium berghei infection.
abstract: The serum from mice developing resistance against Plasmodium berghei infection using chemotherapeutic treatment has been analysed in vivo and in vitro. During the immunization period pathological as well as protective activities which could be transferred by serum were generated. The pathological activity, which was defined as destruction of erythrocytes in normal recipient mice, was generated early in the immunization procedure, peaked at day 21, and decreased to undetectable levels by day 35. After reinfection of the donor mice the pathological activity reappeared in the serum, and was maintained for at least 56 days. Analysis of the transferred serum samples showed the presence of anti-erythrocyte antibodies (ELISA), but no correlation with the in-vivo anti-erythrocyte effect could be found. The anti-erythrocyte effect of the serum samples indirectly increased the parasitaemia in the recipient mice through the induction of reticulocytosis. The protective effect of the serum samples could only be detected in samples taken from animals beyond day 61 of the immunization procedure. This net protective effect was reflected in a decreased parasitaemia at 7 days after challenge of the recipient mice with P. berghei infected erythrocytes. The protective activity of the serum was correlated with high titres of anti-erythrocyte antibodies. Anti-erythrocyte antibody titres were strongly correlated with titres against heterologous red blood cells as well as total immunoglobulin content of the serum samples, indicative of polyclonal activation of lymphocytes. Except for IgG1, all (sub-)classes were elevated during the immunization procedure, of which IgG3 was abundant. After immunity was obtained these immunoglobulin levels remained high, and the relative amount of IgG1 in the serum was restored.
authors.affiliation: Department of Cytology and Histology, University of Nijmegen, The Netherlands.
authors.forename: T P
authors.initials: TP
authors.lastname: Schetters
authors.forename: J H
authors.initials: JH
authors.lastname: Van Run van Breda
authors.forename: C
authors.initials: C
authors.lastname: Hermsen
authors.forename: J
authors.initials: J
authors.lastname: Curfs
authors.forename: W M
authors.initials: WM
authors.lastname: Eling
mesh_terms: D000740:Anemia / Q000276:immunology; D000818:Animals; D001323:Autoantibodies / Q000032:analysis*; D004912:Erythrocytes / Q000276:immunology*; D007106:Immune Sera; D007110:Immunity, Active; D007114:Immunization; D007136:Immunoglobulins / Q000032:analysis; D008288:Malaria / Q000276:immunology* / Q000469:parasitology; D008297:Male; D051379:Mice; D010962:Plasmodium berghei / Q000254:growth & development / Q000276:immunology*; D013997:Time Factors
chemical_list: D001323:Autoantibodies; D007106:Immune Sera; D007136:Immunoglobulins